Capitolis Liquid Global Markets LLC Has $63.89 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Capitolis Liquid Global Markets LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 59.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 126,300 shares of the healthcare conglomerate's stock after selling 187,100 shares during the period. Capitolis Liquid Global Markets LLC's holdings in UnitedHealth Group were worth $63,890,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Principal Financial Group Inc. lifted its stake in UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after buying an additional 180,479 shares in the last quarter. Pensionfund Sabic lifted its stake in shares of UnitedHealth Group by 48.4% during the fourth quarter. Pensionfund Sabic now owns 9,350 shares of the healthcare conglomerate's stock worth $4,730,000 after purchasing an additional 3,050 shares in the last quarter. Kings Path Partners LLC lifted its position in UnitedHealth Group by 11.4% during the 4th quarter. Kings Path Partners LLC now owns 3,300 shares of the healthcare conglomerate's stock worth $1,669,000 after acquiring an additional 338 shares in the last quarter. Fortem Financial Group LLC grew its holdings in UnitedHealth Group by 16.7% during the 4th quarter. Fortem Financial Group LLC now owns 818 shares of the healthcare conglomerate's stock valued at $414,000 after purchasing an additional 117 shares in the last quarter. Finally, Ables Iannone Moore & Associates Inc. lifted its stake in shares of UnitedHealth Group by 1.0% in the fourth quarter. Ables Iannone Moore & Associates Inc. now owns 3,848 shares of the healthcare conglomerate's stock worth $1,947,000 after acquiring an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.9 %

Shares of UNH stock traded down $3.46 during trading hours on Wednesday, reaching $391.05. 8,514,401 shares of the stock traded hands, compared to its average volume of 4,667,653. UnitedHealth Group Incorporated has a 1-year low of $385.87 and a 1-year high of $630.73. The firm has a market capitalization of $355.95 billion, a PE ratio of 25.23, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day moving average price of $491.52 and a 200 day moving average price of $525.18.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm earned $6.91 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.15%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on UNH. JPMorgan Chase & Co. dropped their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Barclays decreased their target price on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. HSBC reaffirmed a "hold" rating and issued a $490.00 price objective on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Truist Financial decreased their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Finally, Mizuho lifted their target price on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.